Exelixis (EXEL) Short Interest Ratio & Short Volume $33.00 -0.68 (-2.02%) (As of 09:00 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Exelixis Short Interest DataExelixis (EXEL) has a short interest of 8.36 million shares, representing 3.00% of the float (the number of shares available for trading by the public). This marks a 5.82% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.9, indicating that it would take 3.9 days of the average trading volume of 2.07 million shares to cover all short positions.Current Short Interest8,360,000 sharesPrevious Short Interest7,900,000 sharesChange Vs. Previous Month+5.82%Dollar Volume Sold Short$304.81 millionShort Interest Ratio3.9 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares285,579,000 sharesFloat Size278,500,000 sharesShort Percent of Float3.00%Today's Trading Volume307 sharesAverage Trading Volume2,073,889 sharesToday's Volume Vs. Average0% Short Selling Exelixis? Sign up to receive the latest short interest report for Exelixis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEXEL Short Interest Over TimeEXEL Days to Cover Over TimeEXEL Percentage of Float Shorted Over Time Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Exelixis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20248,360,000 shares $304.81 million +5.8%3.0%3.9 $36.46 11/15/20247,900,000 shares $272.16 million -13.4%2.8%3.8 $34.45 10/31/20249,120,000 shares $302.78 million -8.6%3.3%4.5 $33.20 10/15/20249,980,000 shares $284.43 million -0.7%3.6%5.1 $28.50 9/30/202410,050,000 shares $260.80 million -20.8%3.6%5.7 $25.95 9/15/202412,690,000 shares $335.78 million +5.5%4.6%7.2 $26.46 Get the Latest News and Ratings for EXEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exelixis and its competitors with MarketBeat's FREE daily newsletter. 8/31/202412,030,000 shares $313.14 million +2.0%4.3%7 $26.03 8/15/202411,790,000 shares $310.19 million +16.0%4.2%6.6 $26.31 7/31/202410,160,000 shares $238.25 million +12.5%3.7%5.7 $23.45 7/15/20249,030,000 shares $203.63 million -1.7%3.2%5.1 $22.55 6/30/20249,190,000 shares $206.50 million -7.6%3.2%4.9 $22.47 6/15/20249,940,000 shares $216.10 million -4.4%3.5%5 $21.74 5/31/202410,400,000 shares $225.58 million -2.9%3.7%4.9 $21.69 5/15/202410,710,000 shares $226.20 million +11.9%3.8%4.8 $21.12 4/30/20249,570,000 shares $224.51 million +11.0%3.4%4 $23.46 4/15/20248,620,000 shares $195.67 million +26.2%3.0%3.8 $22.70 3/31/20246,830,000 shares $162.08 million -17.2%2.3%2.9 $23.73 3/15/20248,250,000 shares $189.59 million -6.8%2.8%3.6 $22.98 2/29/20248,850,000 shares $193.82 million +5.7%3.0%4 $21.90 2/15/20248,370,000 shares $172.34 million +14.5%2.8%3.9 $20.59 1/31/20247,310,000 shares $159.07 million -14.6%2.5%3.5 $21.76 1/15/20248,560,000 shares $194.31 million +5.6%2.8%3.7 $22.70 12/31/20238,110,000 shares $194.56 million -16.7%2.7%3.5 $23.99 12/15/20239,740,000 shares $228.01 million -0.7%3.2%4.3 $23.41 11/30/20239,810,000 shares $213.96 million +1.1%3.3%4.3 $21.81 11/15/20239,700,000 shares $205.93 million +4.8%3.2%4.2 $21.23 10/31/20239,260,000 shares $190.66 million +8.2%3.1%4 $20.59 10/15/20238,560,000 shares $182.84 million +6.3%2.8%3.7 $21.36 9/30/20238,050,000 shares $175.89 million -4.2%2.6%3.6 $21.85 9/15/20238,400,000 shares $183.20 million +6.6%2.7%3.8 $21.81 8/31/20237,880,000 shares $176.43 million -0.8%2.6%3.2 $22.39 8/15/20237,940,000 shares $171.19 million +23.7%2.6%3.2 $21.56 7/31/20236,420,000 shares $126.54 million +13.6%2.1%2.5 $19.71 7/15/20235,650,000 shares $109.55 million -9.9%N/A2.3 $19.39 6/30/20236,270,000 shares $119.82 million -8.7%N/A2.4 $19.11 6/15/20236,870,000 shares $131.22 million -3.2%N/A2.5 $19.10 5/31/20237,100,000 shares $136.89 million -4.2%N/A2.5 $19.28 5/15/20237,410,000 shares $144.50 million +21.5%N/A2.4 $19.50 4/30/20236,100,000 shares $111.63 million -9.9%N/A2 $18.30 4/15/20236,770,000 shares $131.74 million -4.9%N/A2.1 $19.46How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 3/31/20237,120,000 shares $138.20 million -11.4%N/A2.2 $19.41 3/15/20238,040,000 shares $143.11 million -11.6%N/A2.6 $17.80 2/28/20239,090,000 shares $155.26 million -14.3%N/A3.3 $17.08 2/15/202310,600,000 shares $188.36 million +0.9%N/A4.2 $17.77 1/31/202310,510,000 shares $185.19 million -7.0%N/A4.5 $17.62 1/15/202311,300,000 shares $185.66 million -2.6%N/A4.9 $16.43 12/30/202211,600,000 shares $186.06 million +3.8%N/A5.1 $16.04 12/15/202211,180,000 shares $176.64 million -3.8%N/A4.8 $15.80 11/30/202211,620,000 shares $198.47 million +12.1%N/A5.2 $17.08 11/15/202210,370,000 shares $174.22 million +9.2%N/A4.5 $16.80 10/31/20229,500,000 shares $157.51 million +1.7%N/A3.9 $16.58 10/15/20229,340,000 shares $146.17 million +3.1%N/A4 $15.65 9/30/20229,060,000 shares $142.06 million -3.6%N/A4.1 $15.68 9/15/20229,400,000 shares $161.02 million -3.5%N/A4.3 $17.13 8/31/20229,740,000 shares $172.79 million -13.7%N/A4.2 $17.74 8/15/202211,290,000 shares $219.03 million +33.1%N/A4.5 $19.40 7/31/20228,480,000 shares $177.40 million -14.9%2.9%3 $20.92 7/15/20229,970,000 shares $212.76 million -5.8%3.4%3.5 $21.34 6/30/202210,580,000 shares $220.28 million -11.8%3.7%3.8 $20.82 6/15/202212,000,000 shares $215.28 million +9.7%4.1%4.5 $17.94 5/31/202210,940,000 shares $200.53 million +9.5%N/A4.5 $18.33 5/15/20229,990,000 shares $200.60 million +23.0%N/A4 $20.08 4/30/20228,120,000 shares $181.40 million +18.5%2.6%3.8 $22.34 4/15/20226,850,000 shares $158.17 million -10.7%2.2%3.2 $23.09 3/31/20227,670,000 shares $173.88 million -15.0%2.5%3.5 $22.67 3/15/20229,020,000 shares $183.11 million -19.5%2.9%4.2 $20.30 2/28/202211,210,000 shares $230.14 million -19.5%3.6%5.1 $20.53 2/15/202213,920,000 shares $266.99 million +8.1%4.5%6.4 $19.18 1/31/202212,880,000 shares $233.13 million +7.6%4.2%6.5 $18.10 1/15/202211,970,000 shares $216.90 million +1.6%N/A0 $18.12 12/31/202111,780,000 shares $215.34 million -4.2%3.8%6.3 $18.28 12/15/202112,300,000 shares $219.68 million +7.3%4.0%6.7 $17.86 11/30/202111,460,000 shares $192.41 million +2.2%3.7%6.6 $16.79 11/15/202111,210,000 shares $202.56 million +8.2%3.6%6.2 $18.07 10/29/202110,360,000 shares $222.84 million -2.0%3.4%5.6 $21.51 10/15/202110,570,000 shares $230.64 million +3.4%3.4%5.8 $21.82 9/30/202110,220,000 shares $216.05 million +2.1%3.3%5.2 $21.14 9/15/202110,010,000 shares $204.90 million -3.7%3.3%4 $20.47 8/31/202110,390,000 shares $199.18 million -7.2%3.4%4.3 $19.17 8/13/202111,190,000 shares $204.55 million +0.2%3.6%4.8 $18.28 7/30/202111,170,000 shares $188.21 million +1.0%3.7%4.8 $16.85 7/15/202111,060,000 shares $192.55 million -8.9%3.6%5.1 $17.41 6/30/202112,140,000 shares $221.19 million +6.0%4.0%5.8 $18.22 6/15/202111,450,000 shares $259.23 million +1.5%3.7%7.4 $22.64 5/28/202111,280,000 shares $254.36 million +17.4%3.7%7 $22.55 5/14/20219,610,000 shares $244.57 million -11.9%N/A5.8 $25.45 4/30/202110,910,000 shares $269.37 million -8.3%N/A6.1 $24.69 4/15/202111,900,000 shares $286.20 million -8.6%N/A6.4 $24.05 3/31/202113,020,000 shares $286.05 million -2.0%N/A6.1 $21.97 3/15/202113,290,000 shares $309.39 million +5.2%N/A5.8 $23.28How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 2/26/202112,630,000 shares $277.35 million +1.5%N/A5.4 $21.96 2/12/202112,450,000 shares $274.77 million +2.4%N/A5.1 $22.07 1/29/202112,160,000 shares $271.17 million -6.8%N/A5 $22.30 1/15/202113,050,000 shares $310.33 million -9.7%N/A5.5 $23.78 12/31/202014,450,000 shares $292.03 million +0.5%N/A6.5 $20.21 12/15/202014,380,000 shares $295.65 million -3.6%N/A7 $20.56 11/30/202014,910,000 shares $289.40 million +9.5%N/A7 $19.41 11/15/202013,620,000 shares $274.58 million -4.0%N/A6.6 $20.16 10/30/202014,180,000 shares $296.65 million +53.6%N/A7.4 $20.92 10/15/20209,230,000 shares $217.64 million +2.8%N/A4.7 $23.58 9/30/20208,980,000 shares $219.56 million -9.3%N/A4.4 $24.45 9/15/20209,900,000 shares $248.79 million -3.6%N/A4.7 $25.13 8/31/202010,270,000 shares $228.20 million -5.3%N/A5 $22.22 8/14/202010,840,000 shares $238.26 million -9.3%N/A4.8 $21.98 7/31/202011,950,000 shares $275.93 million +0.2%N/A4.7 $23.09 7/15/202011,930,000 shares $290.73 million -11.2%4.0%4 $24.37 6/30/202013,430,000 shares $318.83 million -17.2%4.5%4 $23.74 6/15/202016,210,000 shares $369.59 million +8.9%5.5%4.5 $22.80 5/29/202014,880,000 shares $367.68 million +0.1%5.0%3.8 $24.71 5/15/202014,860,000 shares $382.79 million -9.7%5.0%3.6 $25.76 4/30/202016,450,000 shares $406.23 million -16.9%5.6%3.9 $24.70 4/15/202019,790,000 shares $360.57 million +11.3%6.7%4.9 $18.22 3/31/202017,780,000 shares $471.70 million +17.0%6.0%4.6 $26.53 3/13/202015,194,900 shares $273.81 million +0.5%5.1%4.4 $18.02 2/28/202015,120,000 shares $231.94 million -3.5%5.1%4.4 $15.34 2/14/202015,660,000 shares $287.99 million -2.9%5.3%4.8 $18.39 1/31/202016,120,000 shares $301.28 million -12.4%5.5%5.2 $18.69 1/15/202018,410,000 shares $356.97 million +1.7%6.3%5.7 $19.39 12/31/201918,100,000 shares $326.16 million +17.0%6.2%6.2 $18.02 EXEL Short Interest - Frequently Asked Questions What is Exelixis' current short interest? Short interest is the volume of Exelixis shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 8,360,000 shares of EXEL short. 3.00% of Exelixis' shares are currently sold short. Learn More on Exelixis' current short interest. What is a good short interest ratio for Exelixis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EXEL shares currently have a short interest ratio of 4.0. Learn More on Exelixis's short interest ratio. Which institutional investors are shorting Exelixis? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exelixis: Jane Street Group LLC, Wolverine Trading LLC, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Walleye Trading LLC, Walleye Capital LLC, Citigroup Inc., LMR Partners LLP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Exelixis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.00% of Exelixis' floating shares are currently sold short. Is Exelixis' short interest increasing or decreasing? Exelixis saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 8,360,000 shares, an increase of 5.8% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Exelixis' float size? Exelixis currently has issued a total of 285,579,000 shares. Some of Exelixis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Exelixis currently has a public float of 278,500,000 shares. How does Exelixis' short interest compare to its competitors? 3.00% of Exelixis' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Exelixis: Alnylam Pharmaceuticals, Inc. (2.63%), Biogen Inc. (1.88%), United Therapeutics Co. (4.75%), Neurocrine Biosciences, Inc. (3.86%), Incyte Co. (3.16%), BioMarin Pharmaceutical Inc. (3.02%), Exact Sciences Co. (6.39%), Repligen Co. (6.34%), Madrigal Pharmaceuticals, Inc. (19.62%), Halozyme Therapeutics, Inc. (6.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Exelixis stock? Short selling EXEL is an investing strategy that aims to generate trading profit from Exelixis as its price is falling. EXEL shares are trading down $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exelixis? A short squeeze for Exelixis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EXEL, which in turn drives the price of the stock up even further. How often is Exelixis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EXEL, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Alnylam Pharmaceuticals Short Interest Biogen Short Interest United Therapeutics Short Interest Neurocrine Biosciences Short Interest Incyte Short Interest BioMarin Pharmaceutical Short Interest Exact Sciences Short Interest Repligen Short Interest Madrigal Pharmaceuticals Short Interest Halozyme Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EXEL) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXEL Stock Alerts